Mayo Clinic

Running trials

• Not yet recruiting

  Discontinuation of Low-Dose Levothyroxine in Older Adults With Subclinical Hypothyroidism

  NCT07787585· Phase 4· Source

• Not yet recruiting

  The Effect of Dry Needling With Electrical Stimulation on Individuals With Restless Legs Syndrome

  NCT05860751· Source

• Not yet recruiting

  The Application of Lifestyle Enhancing Validated Integrative Therapies for Everyday Pain in Cirrhosis

  NCT07792850· Source

• Not yet recruiting

  COMparison Between Anakinra and Tocilizumab in NORSE - "COMBAT-NORSE"

  NCT07281027· Phase 3· Source

• Not yet recruiting

  Surgical Window Study of CM93 in Subjects With Recurrent Glioblastoma (rGBM)

  NCT07927491· Phase 1· Source

• Not yet recruiting

  Dorsal Root Ganglion Stimulation After Lower Motor Neuron Damage

  NCT07619300· Source

• Not yet recruiting

  Laser Interstitial Thermal Therapy (LiTT) With Cemiplimab or Other Chemotherapy in Recurrent Glioblastomas

  NCT07620548· Phase 2· Source

• Not yet recruiting

  RESTORE: Restoring State-dependent Thalamocortical Oscillations in Epilepsy

  NCT07927985· Source

• Recruiting

  EEG-Guided Transcranial Magnetic Stimulation for Adults With Depression

  NCT07862205· Source

• Not yet recruiting

  Peri-procedural Weighted Blanket Use for ECT

  NCT07900646· Source

• Recruiting

  Biomarker Targeted Stimulation for Epileptiform Events

  NCT06424977· Source

• Not yet recruiting

  Acute Stimulation and Modulation of Stereotyped High-Frequency Oscillations

  NCT06898138· Source

• Recruiting

  A Clinical Trial To Investigate The Effect Of EA-230 On Hospital Length Of Stay In Patients With Coronary Artery Disease (CAD) Undergoing Coronary Artery Bypass Grafting (CABG) Surgery.

  NCT07357675· Phase 3· Source

• Not yet recruiting

  Effects of Tirzepatide on Esophagogastric Junction Mechanics, Reflux Burden, and Gastric Physiology in Adults With Obesity

  NCT07893457· Phase 4· Source

• Recruiting

  A Research Study Investigating Denecimig (Mim8) in Adults With Acquired Haemophilia A

  NCT07830732· Phase 3· Source

• Recruiting

  Metyrapone Study for Patients Diagnosed With Mild Autonomous Cortisol Secretion - MACS

  NCT07138274· Phase 2· Source

• Not yet recruiting

  Metformin to Attenuate Progressive Respiratory Decline in Idiopathic Pulmonary Fibrosis

  NCT07520110· Phase 3· Source

• Not yet recruiting

  Single Arm Intervention Trial of DEKA TWIIST TM Insulin Pump Utilizing Tidepool Loop Algorithm in Pregnant People With Pre-existing Type 1 Diabetes

  NCT07808385· Source

• Not yet recruiting

  Dose Schedule Study of BCMA Bispecific Antibody, Elranatamab, for Newly Diagnosed Immunoglobulin Light Chain (AL) Amyloidosis

  NCT07524634· Phase 2· Source

• Recruiting

  Longitudinal Study of Retinal Function in Eyes Treated for Diabetic Macular Edema With Anti-VEGF Agents

  NCT07567833· Phase 4· Source

• Recruiting

  HCMR Re-Imaging Study

  NCT07054073· Source

• Recruiting

  Community-Informed Interventions for Equitable Congestive Heart Failure Management in Primary Care

  NCT07730827· Source

• Recruiting

  GBPDC: Gut-Brain in PD Consortium Master Protocol

  NCT07567794· Source

• Recruiting

  Parasternal Extravascular ICD System Pivotal Clinical Investigation (ALARION EV) Study

  NCT07324031· Source

• Recruiting

  A Study With NVC-001 in Patients With LMNA-related Dilated Cardiomyopathy (SUNBEAM-LMNA)

  NCT07606274· Phase 1/2· Source

• Recruiting

  Managing Depressive Symptoms in ADPKD

  NCT07745920· Source

• Recruiting

  Statins to Prevent Cancer Associated Blood Clots

  NCT07303816· Phase 4· Source

• Recruiting

  A Study of Lirafugratinib in Non-CCA Solid Tumors With FGFR2 Fusion or Rearrangement

  NCT07359820· Phase 2· Source

• Recruiting

  A Study to Evaluate the Efficacy of NIO752 in Participants With Progressive Supranuclear Palsy

  NCT07498426· Phase 3· Source

• Not yet recruiting

  An International Multicenter, Multivendor Evaluation of the Free-Running Framework for Cardiac Function

  NCT07613398· Source

• Recruiting

  A Study Comparing JNJ-79635322 and Teclistamab in Participants With Relapsed or Refractory Multiple Myeloma

  NCT07518186· Phase 3· Source

• Recruiting

  A Study Of Remote Voice Analysis Tool For Diagnosing And Monitoring ME/CFS

  NCT07551999· Source

• Recruiting

  A Study to Compare Linvoseltamab and Daratumumab Treatment in High-Risk Smoldering Multiple Myeloma (HR-SMM)

  NCT07393282· Phase 3· Source

• Recruiting

  ASCEND: Safety and Tolerability of ION337 for the Treatment of Dravet Syndrome

  NCT07531745· Phase 1/2· Source

• Recruiting

  PrP-targeting siRNA Safety & Mechanism Study

  NCT07444580· Phase 1· Source

• Recruiting

  Evaluation of the Fully Closed Loop Omnipod® System in Type 2 Diabetes

  NCT07521475· Source

• Recruiting

  Horizon Two: HR NDMM (MMRC-100)

  NCT07053436· Phase 2· Source

• Recruiting

  A Study of Emavusertib + An Approved Bruton Tyrosine Kinase Inhibitor (BTKi) in Participants With Chronic Lymphocytic Leukemia (CLL) and Other B-cell Malignancies

  NCT07271667· Phase 2· Source

• Recruiting

  A Phase 1 AAV Gene Therapy Trial Evaluating Safety and Preliminary Efficacy of RP-A701 in Subjects With BAG3 Dilated Cardiomyopathy

  NCT07137338· Phase 1· Source

• Recruiting

  Evaluation of the Safety and Efficacy of Abenacianine (VGT-309) to Identify Cancer in Subjects Undergoing Surgery for Cancer in the Lung

  NCT07499674· Phase 3· Source

• Enrolling by invitation

  A Long-Term Follow-Up Study of Subjects Completing the AU-011-301(CoMpass) for Early Choroidal Melanoma

  NCT07338968· Phase 3· Source

• Recruiting

  A Study to Investigate Ubamatamab With and Without Marlotamig (REGN7075) in Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)

  NCT07154290· Phase 2· Source

• Recruiting

  Acute and Chronic Repercussion of Spinal Cord Stimulation After Spinal Cord Injury

  NCT07210411· Source

• Not yet recruiting

  Personalized Antisense Oligonucleotide Therapy for A Single Patient With CHCHD10 ALS (nL18576)

  NCT07423494· Phase 1/2· Source

• Recruiting

  Treatment of Participants With Primary or Secondary Progressive Multiple Sclerosis

  NCT07477639· Phase 1/2· Source

• Recruiting

  A Study Of Deep Learning For Echo Analysis, Tracking, And Evaluation

  NCT07308704· Source

• Recruiting

  A Study of SGT-501 Gene Therapy in Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT)

  NCT07148089· Phase 1· Source

• Recruiting

  Evolutionary Clinical Trial for Novel Biomarker-Driven Therapies

  NCT07340541· Phase 2· Source

• Recruiting

  Longitudinal Autonomic Characterization as a Predictor for Secondary Medical Complications Post-SCI

  NCT07210437· Source

• Recruiting

  Adjuvant Temozolomide ± 5-Aminolevulinic Acid + Low Intensity Diffuse Ultrasound Sonodynamic Therapy System for Newly Diagnosed Glioblastoma

  NCT07225621· Phase 2· Source

Showing 50 of 472.

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

• Heart failure19 recruiting
• Lung cancer16 recruiting
• Colorectal cancer13 recruiting
• Childhood cancers12 recruiting
• Epilepsy11 recruiting
• Ovarian cancer11 recruiting
• Liver and biliary tract cancer10 recruiting
• Coronary artery disease9 recruiting
• High blood pressure9 recruiting
• Obesity9 recruiting
• Prostate cancer9 recruiting
• Pancreatic cancer8 recruiting
• Sarcoma8 recruiting
• Ventricular tachycardia8 recruiting
• Alzheimer disease6 recruiting
• Amyloidosis6 recruiting
• Aortic stenosis6 recruiting
• Barrett's oesophagus6 recruiting
• Gastric and oesophageal cancer6 recruiting
• Liver cirrhosis6 recruiting
• Multiple myeloma6 recruiting
• Stroke6 recruiting
• Triple-negative breast cancer6 recruiting
• Congenital heart disease5 recruiting
• Melanoma5 recruiting
• Metastatic breast cancer5 recruiting
• Parkinson disease5 recruiting
• Pulmonary arterial hypertension5 recruiting
• Aortic aneurysm4 recruiting
• Chronic kidney disease4 recruiting
• Cushing's syndrome4 recruiting
• Depression4 recruiting
• Frontotemporal dementia4 recruiting
• Glioblastoma4 recruiting
• Kidney cancer4 recruiting
• Lewy body dementia4 recruiting
• Polycystic kidney disease4 recruiting
• Spinal cord injury4 recruiting
• Ulcerative colitis4 recruiting
• Acute myeloid leukaemia3 recruiting
• Atrial fibrillation3 recruiting
• Bladder cancer3 recruiting
• Chronic lymphocytic leukaemia3 recruiting
• Crohn's disease3 recruiting
• Dilated cardiomyopathy3 recruiting
• Endometrial cancer3 recruiting
• Fatty liver disease (MASLD/MASH)3 recruiting
• Head and neck cancer3 recruiting
• Hypertrophic cardiomyopathy3 recruiting
• Multiple sclerosis3 recruiting
• Multiple system atrophy3 recruiting
• Obstructive sleep apnoea3 recruiting
• Osteoarthritis3 recruiting
• Primary biliary cholangitis3 recruiting
• ALS (motor neurone disease)2 recruiting
• Bipolar disorder2 recruiting
• Cervical cancer2 recruiting
• Chronic myeloid leukaemia2 recruiting
• Coeliac disease2 recruiting
• Diabetic eye disease2 recruiting
• Hearing loss2 recruiting
• Idiopathic pulmonary fibrosis2 recruiting
• Irritable bowel syndrome2 recruiting
• Long COVID and ME/CFS2 recruiting
• Lupus (SLE)2 recruiting
• Mantle cell lymphoma2 recruiting
• Mesothelioma2 recruiting
• Migraine2 recruiting
• Myocarditis2 recruiting
• Neuroendocrine tumours2 recruiting
• Peripheral artery disease2 recruiting
• Retinitis pigmentosa2 recruiting
• Rheumatoid arthritis2 recruiting
• Type 2 diabetes2 recruiting
• Vascular dementia2 recruiting
• ANCA-associated vasculitis1 recruiting
• Aplastic anaemia1 recruiting
• Brain aneurysm1 recruiting
• Bronchiectasis1 recruiting
• Charcot-Marie-Tooth disease1 recruiting
• Cystic fibrosis1 recruiting
• Cytomegalovirus infection1 recruiting
• Diffuse large B-cell lymphoma1 recruiting
• Dystonia1 recruiting
• Endometriosis1 recruiting
• Essential tremor1 recruiting
• Friedreich ataxia1 recruiting
• Haemophilia1 recruiting
• Hepatitis B1 recruiting
• Hepatitis C1 recruiting
• Hydrocephalus1 recruiting
• Hypothyroidism1 recruiting
• Immune thrombocytopenia (ITP)1 recruiting
• Insomnia1 recruiting
• Macular degeneration1 recruiting
• Meningioma1 recruiting
• Myasthenia gravis1 recruiting
• Neuroblastoma1 recruiting
• Postural tachycardia syndrome (POTS)1 recruiting
• Psoriasis1 recruiting
• Psoriatic arthritis1 recruiting
• Restless legs syndrome1 recruiting
• Sarcoidosis1 recruiting
• Sjögren's disease1 recruiting
• Systemic sclerosis (scleroderma)1 recruiting
• Type 1 diabetes1 recruiting

Researchers

No researcher is linked here yet.

Closed trials

• Withdrawn

  Glucose and Blood Pressure During Pregnancy

  NCT04979312· Source

• Withdrawn

  Impact of Insulin Deprivation and Hyperglycemia on Plasma Protein Synthesis in People With Type 1 Diabetes Mellitus

  NCT05985135· Source

• Recruiting

  Renal Pelvic Denervation Pilot Trial

  NCT07005050· Source

• Completed

  Accuracy of a Cuffless Photoplethysmography (PPG) Chest-Patch Monitor for 24-hour Ambulatory Blood Pressure Monitoring (ABPM)

  NCT07240831· Source

• Completed

  NAL ER IPF Respiratory Function and Safety Study

  NCT07036029· Phase 1· Source

• Completed

  The Clinical Impact of Integrated Behavioral Health Techniques in Patients With Fibromyalgia

  NCT06988761· Source

• Recruiting

  Prevention of Ototoxicity in NTM Patients Treated With IV Amikacin

  NCT05730283· Phase 2· Source

• Completed

  NE3107 in Adults With Neurological Symptoms of Long COVID

  NCT06847191· Phase 2· Source

• Completed

  Innovative Automated Insulin Delivery System for Type 2 Diabetes

  NCT06853990· Source

• Completed

  Validation of Plant-Based Vegan Meal for Gastric Emptying Testing in 10 Healthy Subjects

  NCT06991036· Source

• Completed

  REVEAL - Research With I-124 EVuzamitide to Elucidate Cardiac AmyLoidosis

  NCT06788535· Phase 3· Source

• Completed

  A Study of the TactiFlex SE Catheter and Volt PFA Generator in Subjects With PAF:

  NCT06676072· Source

• Completed

  Study of Natriuretic Peptide Receptor 1 (NPR1) Antagonist in Adult Patients With Postural Orthostatic Tachycardia Syndrome (POTS)

  NCT06593600· Phase 2· Source

• Completed

  Study Evaluating the Safety and Efficacy of RAP-219 in Adult Participants With Refractory Focal Epilepsy

  NCT06377930· Phase 2· Source

• Terminated

  ICoN-1 Phase 3 Study of the Efficacy and Safety of Treatment With MNKD-101, Clofazimine Inhalation Suspension

  NCT06418711· Phase 3· Source

• Completed

  RECOVER-ENERGIZE Platform Protocol

  NCT06404047· Source

• Completed

  Intestinal Ultrasound for the Evaluation of Pouchitis and Other Outcomes After Ileal Pouch-Anal Anastomosis

  NCT06316999· Source

• Recruiting

  Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia (FETO)

  NCT03138863· Source

• Completed

  Shared Decision Making for Kidney Transplant Candidates to Plan for an Organ Offer Decision

  NCT05879302· Source

• Completed

  A Study to Test if Trevogrumab or Trevogrumab With Garetosmab When Taken With Semaglutide is Safe and How Well They Work in Adult Patients With Obesity for Weight Loss, Fat Loss, and Lean Mass Preservation

  NCT06299098· Phase 2· Source

• Completed

  Investigational Extended Wear Insulin Infusion Set in People With Type 1 Diabetes

  NCT06273124· Source

• Completed

  A Study to Investigate the Efficacy and Safety of Verekitug (UPB-101) in Adult Participants With Severe Asthma (VALIANT)

  NCT06196879· Phase 2· Source

• Completed

  Non-invasive Vagal Neurostimulation (nVNS) in Adolescents With Postural Orthostatic Tachycardia Syndrome (POTS)

  NCT06268288· Source

• Completed

  Abdominal Aorta Palpation With Point of Care Ultrasound Imaging Measurements

  NCT06211946· Source

• Completed

  Autologous Alpha-2 Macroglobulin Rich Plasma, Safety and Efficacy in Symptomatic Moderate Knee Osteoarthritis

  NCT06329492· Phase 1/2· Source

• Completed

  "Embolization Before Ablation of Renal Cell Carcinoma (EMBARC)"

  NCT05410509· Source

• Recruiting

  BradycArdia paCemaKer With AV Interval Modulation for Blood prEssure treAtmenT

  NCT06059638· Source

• Completed

  Aqueous Humor Dynamics of NCX 470 Ophthalmic Solution

  NCT05938699· Phase 2/3· Source

• Completed

  Multi-Institutional Transgender & Gender-Diverse Breast Cancer Study

  NCT06234488· Source

• Completed

  A Study of Remote Asthma Management Using an Integrated Artificial Intelligence-assisted EHR Dashboard and Mobile Device Compared With Usual Asthma Care to Treat 6-17 Year Old Patients

  NCT06062433· Source

• Completed

  R-5280 in Newly Diagnosed Patients With Type 1 Diabetes

  NCT06057454· Phase 1· Source

• Completed

  Treatment of AA Amyloidosis

  NCT06397001· Phase 1· Source

• Terminated

  Randomized, Double-blind Study of Efficacy and Safety of Bexotegrast (PLN-74809) for Idiopathic Pulmonary Fibrosis

  NCT06097260· Phase 2· Source

• Completed

  Retrospective Experience Assessing the Real-World Utilization and Effectiveness of SEVENFACT®

  NCT05904210· Source

• Completed

  Bipolar Disorder Measures in Clinical Care

  NCT05300919· Source

• Completed

  Phase 2B Safety and Efficacy Study of VGT-309 in Subjects With Cancer in the Lung.

  NCT06145048· Phase 2· Source

• Completed

  HEAL-LAA Clinical Trial

  NCT05809596· Source

• Completed

  Epidural Stimulation in Multiple Sclerosis

  NCT06019611· Source

• Terminated

  Study of EO-3021 in Adult Patients With Solid Tumors Likely to Express CLDN18.2

  NCT05980416· Phase 1· Source

• Terminated

  Treatment of an Inherited Ventricular Arrhythmia

  NCT05122975· Phase 2· Source

• Completed

  STENOVA - A Study to Evaluate Safety, Tolerability, PK and PD of AGMB-129 in Patients With Fibrostenotic Crohn's Disease

  NCT05843578· Phase 2· Source

• Completed

  RECOVER-VITAL: Platform Protocol to Measure the Effects of Antiviral Therapies on Long COVID Symptoms

  NCT05595369· Phase 2· Source

• Completed

  A Phase 1 Study of BMF-500 in Adults With Acute Leukemia

  NCT05918692· Phase 1· Source

• Terminated

  A Study to Evaluate Safety and Effectiveness of G-POEM for Gastroparesis

  NCT04869670· Source

• Completed

  INHALE-3: Afrezza® Combined With Insulin Degludec Versus Usual Care in Adults With Type 1 Diabetes

  NCT05904743· Phase 4· Source

• Terminated

  Efficacy, Safety and Tolerability of VS-01 in Adult Patients With Acute-on-Chronic Liver Failure and Ascites (UNVEIL-IT)®

  NCT05900050· Phase 2· Source

• Recruiting

  The Canadian CABG or PCI in Patients With Ischemic Cardiomyopathy Trial (STICH3C)

  NCT05427370· Source

• Completed

  IS-002 Phase 2 Prostate Cancer Study

  NCT05946603· Phase 2· Source

• Completed

  A Randomized Trial Evaluating Control-IQ+ Technology in Adults With Type 2 Diabetes

  NCT05785832· Source

• Completed

  Safety and Toxicity Study of Intravesical Instillation of TARA-002 in Adults with High-grade Non-muscle Invasive Bladder Cancer (Phase 1b)

  NCT05085990· Phase 1· Source

Showing 50 of 232.